paper-with-me

홈 › Papers

A randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management

2024-09-03 · Abdelmalek Mouazer, Sophie Dubois, Romain Léguillon, Nada Boudegzdame, Thibaud Levrard, Yoann Le Bars, Christian Simon, Brigitte Séroussi, Julien Grosjean, Romain Lelong, Catherine Letord, Stéfan Darmoni, Karima Sedki, Pierre Meneton, Rosy Tsopra, Hector Falcoff, Jean-Baptiste Lamy

Background: Medication review is a structured interview of the patient, performed by the pharmacist and aimed at optimizing drug treatments. In practice, medication review is a long and cognitively-demanding task that requires specific knowledge. Clinical practice guidelines have been proposed, but their application is tedious. Methods: We designed ABiMed, a clinical decision support system for medication reviews, based on the implementation of the STOPP/START v2 guidelines and on the visual presentation of aggregated drug knowledge using tables, graphs and flower glyphs. We evaluated ABiMed with 39 community pharmacists during a randomized simulation trial, each pharmacist performing a medication review for two fictitious patients without ABiMed, and two others with ABiMed. We recorded the problems identified by the pharmacists, the interventions proposed, the response time, the perceived usability and the comments. Pharmacists' medication reviews were compared to an expert-designed gold standard. Results: With ABiMed, pharmacists found 1.6 times more relevant drug-related problems during the medication review (p=1.1e-12) and proposed better interventions (p=9.8e-9), without needing more time (p=0.56). The System Usability Scale score is 82.7, which is ranked "excellent". In their comments, pharmacists appreciated the visual aspect of ABiMed and its ability to compare the current treatment with the proposed one. A multifactor analysis showed no difference in the support offered by ABiMed according to the pharmacist's age or sex, in terms of percentage of problems identified or quality of the proposed interventions. Conclusions: The use of an intelligent and visual clinical decision support system can help pharmacists when they perform medication reviews. Our main perspective is the validation of the system in clinical conditions.

📄 PDF Abstract BibTeX arXiv:2409.01903

Code (0)

등록된 구현이 없습니다.

Tasks

Management

Similar Papers 제목 키워드 기반

ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management

2023-12-13 · Abdelmalek Mouazer, Romain Léguillon, Nada Boudegzdame, Thibaud Levrard 외

Background: Polypharmacy, i.e. taking five drugs or more, is both a public health and an economic issue. Medication reviews are structured interviews of the patient by the community pharmacist, aiming at optimizing the d…

Management

Two-Stage Penalized Regression Screening to Detect Biomarker-Treatment Interactions in Randomized Clinical Trials

2020-04-25 · Jixiong Wang, Ashish Patel, James M. S. Wason, Paul J. Newcombe

High-dimensional biomarkers such as genomics are increasingly being measured in randomized clinical trials. Consequently, there is a growing interest in developing methods that improve the power to detect biomarker-treat…

regression

Assessing Surrogate Heterogeneity in Real World Data Using Meta-Learners

2025-04-21 · Rebecca Knowlton, Layla Parast

Surrogate markers are most commonly studied within the context of randomized clinical trials. However, the need for alternative outcomes extends beyond these settings and may be more pronounced in real-world public healt…

Evaluation of machine-learning models to measure individualized treatment effects from randomized clinical trial data with time-to-event outcomes

2025-06-13 · Elvire Roblin, Paul-Henry Cournède, Stefan Michiels

In randomized clinical trials, regression models can be used to explore the relationships between patients' variables (e.g., clinical, pathological or lifestyle variables, and also biomarker or genomics data) and the mag…

Towards Regulatory-Confirmed Adaptive Clinical Trials: Machine Learning Opportunities and Solutions

2025-03-12 · Omer Noy Klein, Alihan Hüyük, Ron Shamir, Uri Shalit 외

Randomized Controlled Trials (RCTs) are the gold standard for evaluating the effect of new medical treatments. Treatments must pass stringent regulatory conditions in order to be approved for widespread use, yet even aft…

Active Learning